Filter
323
Filtered Results: 323
Text search:
Government
of
India,
Central
Tuberculosis
Division,
Ministry
of
Health
and
Family
Welfare
Featured
Recommendations
21
New Publications
138
Language
Document type
No document type
230
Studies & Reports
43
Guidelines
24
Manuals
12
Strategic & Response Plan
7
Situation Updates
4
Training Material
2
Fact sheets
1
Countries / Regions
India
93
Nepal
25
Bangladesh
13
Myanmar / Burma
12
Global
11
Kenya
9
Rwanda
8
Asia
7
South–East Asia Region
7
Western and Central Europe
6
Uganda
6
Africa
5
Ethiopia
5
South Africa
4
Nigeria
3
Malawi
3
Latin America and the Carribbean
3
Namibia
3
Indonesia
3
Lesotho
2
Ghana
2
Sierra Leone
2
Afghanistan
2
Mozambique
2
Jordan
2
Middle East and North Africa
2
Eastern Europe
2
Sri Lanka
2
Colombia
1
Thailand
1
Syria
1
Iran
1
Senegal
1
Burundi
1
Zimbabwe
1
Haiti
1
Tanzania
1
West and Central Africa
1
Eastern Europe and Central Asia
1
Maldives
1
East and Southern Africa
1
Bhutan
1
Botswana
1
South Sudan
1
Somalia
1
Liberia
1
Pakistan
1
Authors & Publishers
Publication Years
Category
Countries
185
Clinical Guidelines
14
Public Health
11
Women & Child Health
9
Key Resources
7
Capacity Building
1
Pharmacy & Technologies
1
Toolboxes
TB
33
HIV
31
AMR
16
COVID-19
9
NTDs
7
Global Health Education
7
Rapid Response
6
Mental Health
6
Refugee
5
Pharmacy
5
Health Financing Toolbox
5
Malaria
5
Disability
3
Caregiver
3
Planetary Health
3
Conflict
3
Natural Hazards
1
NCDs
1
Zika
1
Polio
1
The 2013 RMIS is a nationally representative, household-based survey that provides data on malaria indicators, which are used to assess the progress of a malaria control program. The primary objective of the 2013 Rwanda Malaria Indicator Survey (2013 RMIS) was to provide up-to date information on th...
The purpose of this book is to provide an overview of Buruli ulcer (Mycobacterium ulcerans infection) for the medical and scientific communities and the general public alike.
One of the first steps in developing a multisectoral action plan (MSAP) is to use a situation analysis to provide a comprehensive assessment of the health needs, prevailing risks and the context of the area to which the plan will apply. This will help countries, regions, provinces or cities intendi...
The UK government hosted the Global Vaccine Summit on June 4, 2020 under the patronage of the Rt. Hon. Boris Johnson, Prime Minister of the United Kingdom of Great Britain and Northern Ireland. The meeting was held by videoconference in light of the ongoing COVID-19 pandemic. 2. The Summit brought...
During the first two years of the project (2019–2020), through a ‘One Health’ approach, comprehensive engagement was established with AMR coordinating committees, WHO regional and country offices and SORT IT partners in Asia, Africa, Europe and the Americas. Thirty-seven research studies were ...
The strategic priorities of the CCS 2014–2018 are:
(1) Strengthening the health system.
(2) Enhancing the achievement of communicable disease control targets.
(3) Controlling the growth of the noncommunicable disease burden.
(4) Promoting health throughout the life course.
...
(1) Strengthening the health system.
(2) Enhancing the achievement of communicable disease control targets.
(3) Controlling the growth of the noncommunicable disease burden.
(4) Promoting health throughout the life course.
...
Antimicrobial resistance (AMR) has emerged as a leading cause of death in the African region, surpassing fatalities from malaria, HIV, and TB. In response to this critical threat, the region has adopted the AMR Global Action Plan and the African Union Framework for Antimicrobial Resistance Control 2...
This guide provides an overview of the major elements that must be considered before, during and after the implementation of antigen-detecting rapid diagnostic tests (Ag-RDTs) for SARS-CoV-2. This guide is complementary to policy guidance issued by the World Health Organization (WHO). The guide may ...
mhGAP is based on evidence-based technical guidelines (4) and provides a set of tools and
training packages to extend service provision. The mhGAP Intervention Guide (mhGAP-IG)
for MNS disorders in non-specialized health settings (8) is a clinical decision-making tool
for assessing and managing p...
• provide scientific information on the safety, efficacy, and quality control/ quality assurance of widely used medicinal plants, in order to facilitate their appropriate use in Member States;
• provide models to assist Member States in developing their own mono- graphs or formularies for these...
WHO Guideline. Since 2010, countries in the meningitis belt have started to introduce a new serogroup A meningococcal conjugate vaccine conferring individual protection and herd immunity. Following the successful roll-out of this vaccine, epidemics due to Neisseria meningitidis serogroup A (NmA) are...
World malaria report 2024
recommended
New data from the WHO reveal that an estimated 2.2 billion cases of malaria and 12.7 million deaths have been averted since 2000, but the disease remains a serious global health threat, particularly in the WHO African Region. According to WHO’s latest World malaria report, there were an estimated ...
This toolkit for integrated vector management (IVM) is designed to help national and regional programme managers coordinate across sectors to design and run large IVM programmes.
The toolkit provides the technical detail required to plan, implement, monitor and evaluate an IVM approach. IVM can...
The toolkit provides the technical detail required to plan, implement, monitor and evaluate an IVM approach. IVM can...
WHO Living guideline: Drugs to prevent COVID-19
recommended
Interim guidance 2 march 2021
Current use of drugs to prevent COVID-19 is variable, reflecting large-scale uncertainty. Numerous randomized trials of many different drugs are underway to inform practice. This first version of the Drugs to prevent COVID-19: A WHO living guideline contains new inform...
The WHO Living guideline: Drugs to prevent COVID-19 contains the Organization’s most up-to-date recommendations for the use of drugs to prevent COVID-19. The latest version of this living guideline is available in pdf format (via the ‘Download’ button) and via an online platform.
Guidelines ...
Annual report on global preparednessfor health emergencies
The next pandemic is not a question of if, but when—and the world is woefully unprepared, according to the first annual report from the Global Preparedness Monitoring Board. The WHO and the World Bank convened the independent group after ...
Has the world worked together to tackle the coronavirus? July 2021. This research paper assesses how the global community has responded to calls for greater solidarity in tackling the COVID-19 pandemic, and presents the insights of key stakeholders and experts in global health governance, health sec...
Disease Control Priorities, 3rdEdition: Volume 4.
Mental, neurological, and substance use disorders are common, highly disabling, and associated with significant premature mortality. The impact of these disorders on the social and economic well-beingof individuals, families, and societies is large...
Celebrating ten years of success 2004-2014
India AIDS Response Report 2014
